ABEO - Company ID 0000318306
The table below shows ABEONA THERAPEUTICS INC.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$19.80M | -$18.40M | -$14.54M | -$11.74M | -$13.69M | -$13.59M |
| Capital expenditure | $935.00K | $1.40M | $725.00K | $218.00K | $103.00K | $444.00K |
| Investing cash flow | $4.96M | $4.21M | -$7.82M | $2.21M | $1.07M | $9.38M |
| Dividends paid | - | - | - | - |
ABEONA THERAPEUTICS INC. reported operating cash flow of -$76.33M for fiscal year 2025. That is down 36.3% from -$56.02M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$13.01M (FY 2016) to -$76.33M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | -$2.22M | $6.77M | $25.44M | -$4.00K | - | $5.88M |